The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said ...
BridgeBio Pharma Inc. (BBIO) announced that the U.S. Food and Drug Administration approved Attruby or acoramidis, an ...
The latest health news highlights BridgeBio's new heart drug approved by the FDA, novel findings in breast cell research, ...
‘We dodged a bullet’: Biotech and pharma react to selection of Marty Makary for FDA commissioner
It is fair to say that far more individuals aside from the commissioner are instrumental as far as the drug review and ...
It is a fictional representation created for illustrative purposes only. The U.S. Food and Drug Administration has approved ...
The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as needed. Recent ...
BridgeBio secured approval for Attruby Friday, along with the all-important mortality benefit that could give the drug a ...
BridgeBio Pharma (BBIO) wins FDA nod Attruby for rare heart disorder, ATTR-CM challenging Pfizer's (PFE) Vyndaqel. Read more ...
“In summary, our science-led strategy is delivering compelling proof points that we are creating a sustainable innovation ...
The Food and Drug Administration is now focused on activities, which may include additional surveillance, as well as prevention and compliance activities. Health officials are urging people to ...
Subscribe to Sky Sports to watch live, or stream on NOW. You'll need a subscription that includes Sky Sports News.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback